Maraviroc Tablet, Film Coated
Product Images NDC 73141-024

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Maraviroc (NDC 73141-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A2a Integrated Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mg (150mg)

This is a description of a medication called Maraviroc, which is available in the form of tablets containing 150 mg of the active ingredient. It provides information on the proper storage conditions (between 20°C to 25°C) and instructions to follow the prescribing information for dosage details. The medication should be dispensed in containers with a printed safety seal intact. The text also mentions that the medication guide should always be dispensed with the tablets. The distributed by information is for A2A Integrated Pharmaceuticals in Bowling Green, KY.*

FDA Label Image

300mg (300mg)

This is a description of a medication with National Drug Code (NDC) 73141-025-02, containing 60 tablets of Maraviroc. Each tablet has 300 mg of Maraviroc. The prescription drug should always be dispensed with a medication guide. It is to be stored at 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F). It is important not to use if the safety seal is broken or missing. The medication is distributed by A2A Integrated Pharmaceuticals in Bowling Green, KY.*

FDA Label Image

Chem-structure.jpg (Chem Structure.jpg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.